Meropenem Fresenius i.v. 500 mg

Meropenem Fresenius i.v. 500 mg is a medicine authorised by Swissmedic under authorisation number 62419. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 December 2011 and the authorisation is valid without a time limit. ATC code J01DH02 places the medicine in the group Antibacterials for systemic use.

  • Dispensing category A
  • Authorisation number 62419
  • ATC J01DH02
  • Synthetic medicines
Authorisation data
Authorisation number62419
NameMeropenem Fresenius i.v. 500 mg
Full nameMeropenem Fresenius i.v. 500 mg, Pulver zur Herstellung einer Injektions-/Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ01DH02
First authorisation13 December 2011
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Meropenem Fresenius i.v. 500 mg, Pulver zur Herstellung einer Injektions-/InfusionslösungA13 December 2011
2Meropenem Fresenius i.v. 1 g, Pulver zur Herstellung einer Injektions-/InfusionslösungA13 December 2011

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110 x 500mgJ01DH0208.01.25A
210 x 1gJ01DH0208.01.25A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Meropenem Fresenius i.v. 500 mg authorised in Switzerland?

Yes. Meropenem Fresenius i.v. 500 mg is authorised by Swissmedic under authorisation number 62419, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Meropenem Fresenius i.v. 500 mg have?

Meropenem Fresenius i.v. 500 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Meropenem Fresenius i.v. 500 mg?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com